Healthcare IB specific techs
Have an upcoming interview for healthcare IB. Wondering if there may be any techs specific to healthcare and if so, what those questions would be.
Trending Content - Investment Banking Forum
| +380 | Don’t work at UBS - UBS Sucks | 37 | 6h |
| +327 | Article - UBS’ Investment Bank Keeps Losing Ground | 41 | 1d |
| +133 | Should My Intern Get a Return Offer? | 46 | 1h |
| +61 | When to Leave Office as Intern | 8 | 4d |
| +55 | Best IB Group Overall? | 32 | 12h |
| +54 | F*ck it I'm Going to Med School | 19 | 1h |
| +39 | Would you rather be a Touse Squid or a Bouse Mogger in IB | 2 | 4d |
| +33 | What do you say to ppl who don’t know EVR/LAZ/CVP/PJT | 28 | 1d |
| +31 | STEM student lost in London IB recruiting | 17 | 2d |
| +27 | [HELP REQUESTED]: Take A2A Promo or Go Corp Dev | 9 | 19h |
Career Resources
You need to give details
BB? EB? MM?
Location?
Biopharma EB, West Coast US
Is there any subsector focus?
Biopharma. Got the interview out of nowhere. Prepping frantically.
Is this for lateral or after graduation role?
When did you apply?
Modeling in biotech is all probability of success weighted SOTP and DCF, so be comfortable talking about that. Revenue builds are market models with a patient build and average selling price.
Drug will get developed/approved and eventually lose exclusivity after a certain # of years, so need to constantly derisking revenue forecast by adding on to the pipeline through R&D, acquisitions, or commercialization partnerships.
Some trends: large pharma has lots of cash right now to be acquisitive and buy down SMID names whos valuation is getting pushed down lately.
All of this should be a good starting point, can’t imagine you get asked anything too in-depth.
Look in the WSP Red Book - very helpful industry-specific questions
Some things for you to think about:
What are key aspects to focus on to assess a drug?
MOA, modality, development stage, indication
Find the DB “pharmaceuticals for beginner” if uou have access to research - it’s from 2012 but will give you good overview of drug development process
There is a cohen report on the fda approval process too - recently updated
How to think about development timelines, PTRS, peak sales, typical cost ratios
When do companies get bought? What do buyers wait to see before pressing the button?
Who are the buyers?
How do they assess a project? (Risk adjusted vs non adjusted, IRR + NPV, payback, value share…)
If you google “biotech caluation model xls” you’ll find a sample model from BIWS on Jazz. Worth taking a look at
I wasn't able to find the BIWS model, any chance you could link me to it?
What the other two certified posters have said is fantastic. Additionally, it can’t hurt to be familiar with funding mechanisms like contingent value rights (CVR) and milestone payments which are common in the early-stage of the industry. Best of luck!
Types of M&A in biopharma are going to different. You will see a lot of deals with upfront + CVRs upon clinical/regulatory/commercial milestones. Also a lot of asset level licensing deals, where the client isn’t selling the entire company but only the commercial rights to a drug in a licensed territory (can be US/WW/ex-US…..etc) in exchange for an upfront + milestones + tiered royalty streams based on future sales of the product
flip through these. ive never done biotech, but these helped me sound halfway competent while interviewing for biotech banking roles:
https://bluestarbioadvisors.com/resources/docs/bluestar-bioadvisors-val…
https://www.toptal.com/finance/valuation/biotech-valuation
Read about recent industry trends so the group selection seems like a choice rather than opportunism. Be ready to talk about a company or a technology that interests you like AI drug discovery and Schrödinger.
Asperiores voluptatem consequatur eaque quo harum. Odit aut sunt laboriosam. Sunt vitae pariatur incidunt nobis eos iste. Accusantium debitis eligendi temporibus debitis.
Et velit non blanditiis libero. Vel quo laudantium perferendis corrupti eveniet at ratione saepe. At non perferendis doloribus aut optio. Repudiandae sint sunt unde quisquam nihil ut eius est.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...